Polysaccharide vaccines: determinants of clinical efficacy.
Many common bacteria cause disease because their polysaccharide capsules prevent phagocytosis. Antibody directed against these capsules is the basis for some of the most effective bacterial vaccines. Nevertheless, many diseases caused by such bacteria continue to cause serious morbidity. Recent findings indicate that several previously unrecognized factors (most notably, genetics) determine responsiveness to capsular polysaccharides.